CLARENCE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (OTCBB: XXII), a company focused on smoking cessation and tobacco harm reduction products, today announced X-22, a prescription smoking ...

22nd Century Group has reduced debt by $3.8 million, now totaling approximately $3.9 million, supporting growth initiatives. 22nd Century Group, Inc. has announced a significant debt reduction, ...

MOCKSVILLE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a ...

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (OTCBB: XXII), a company focused on smoking cessation and tobacco harm reduction products, announced today that enrollment of its X-22 Phase ...

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on tobacco harm reduction, is pleased to announce that the 2013 Research ...

22nd Century Group, Inc. beats earnings expectations. Reported EPS is $-48.96, expectations were $-648. Operator: Welcome to 22nd Century Group’s Fourth Quarter and Full Year 2024 Conference Call and ...

22nd Century Group, Inc. (NASDAQ:XXII) Q1 2025 Earnings Call Transcript May 13, 2025 22nd Century Group, Inc. misses on earnings expectations. Reported EPS is $-1.89 EPS, expectations were $-1.1.

Welcome to 22nd Century Group's First Quarter 2025 Conference Call and Webcast. At this time, all participants have been placed in a listen-only mode. It is now my pleasure to turn the floor over to ...

22nd Century Group, Inc. misses on earnings expectations. Reported EPS is $-1.89 EPS, expectations were $-1.1. Operator: Welcome to 22nd Century Group’s First Quarter 2025 Conference Call and Webcast.

Good morning, and welcome to the 22nd Century Group's Second Quarter 2025 Results Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over ...